Abstract
Drug prices and cost of healthcare are two major concerns globally. This entails to examine the structure and performance of domestic pharmaceutical industry and Indian market’s pricing policy of drugs. This article contributes to the debate around regulation of drug prices in India from the perspectives of the healthcare of the poor and affordability.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
